Clinical trial
Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer
NCT00040742 · Gary Morrow, Other · Completed
Key facts
| NCT number | NCT00040742 |
|---|---|
| Title | Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer |
| Official title | A Phase II/III Randomized, Controlled Clinical Trial Of Ginger (Zingiber Officinale) For Nausea Caused By Chemotherapy For Cancer |
| Lead sponsor | Gary Morrow, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Nausea, Vomiting |
| Intervention type | Dietary Supplement, Other |
| Interventions | ginger, placebo |
| Enrollment | 745 |
| Start date | Mar 1, 2003 |
| Primary completion | Aug 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 9, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: